ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,170Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 783

$707K Total Retail Price of All Prescriptions

Rank: 133 out of 783

567 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,902 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 627 483 1 5
FUROSEMIDE 439 361 2 7
METOPROLOL TARTRATE 381 284 3 9
LISINOPRIL 345 260 4 4
SIMVASTATIN 331 254 5 3
OMEPRAZOLE 324 235 6 6
METFORMIN HCL 310 232 7 8
HYDROCODONE-ACETAMINOPHEN 284 161 S3 8 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 262 188 9 33
GABAPENTIN 261 162 10 15
ATENOLOL 236 183 11 17
POTASSIUM CHLORIDE 211 143 12 16
HYDROCHLOROTHIAZIDE 179 126 13 12
HYDRALAZINE HCL 175 147 14 78
LEVOTHYROXINE SODIUM 174 136 15 1
FAMOTIDINE 172 126 16 55
LANTUS 167 112 17 38
PRAVASTATIN SODIUM 150 105 18 14
TRAMADOL HCL 150 122 18 20
DIGOXIN 144 112 20 61
CLOPIDOGREL 142 125 21 29
ATORVASTATIN CALCIUM 134 99 22 11
METOPROLOL SUCCINATE 128 100 23 13
CRESTOR 120 90 24 27
PANTOPRAZOLE SODIUM 108 81 25 30
KLOR-CON M20 107 100 26 48
DIOVAN 107 73 26 49
PLAVIX 102 85 28 51
WARFARIN SODIUM 100 73 29 10
DONEPEZIL HCL 98 98 30 24
CLONIDINE HCL 97 71 31 60
CYCLOBENZAPRINE HCL 93 55 R 32 63
CIPROFLOXACIN HCL 92 83 33 62
LEVOFLOXACIN 92 71 33 75
PROAIR HFA 91 49 35 56
SERTRALINE HCL 87 71 36 22
LOSARTAN-HYDROCHLOROTHIAZIDE 83 64 37 53
CARVEDILOL 78 59 38 21
TRAMADOL HCL-ACETAMINOPHEN 75 62 39 167
GLIPIZIDE 74 52 40 71
NASONEX 73 50 41 338
NAPROXEN 72 49 42 104
LOSARTAN POTASSIUM 68 56 43 18
INSULIN SYRINGE 66 35 44 82
METOCLOPRAMIDE HCL 65 53 45 121
SINGULAIR 61 37 46 90
VENTOLIN HFA 59 32 47 159
AMLODIPINE BESYLATE-BENAZEPRIL 58 35 48 83
DIOVAN HCT 58 48 48 94
FENTANYL 58 52 S2 48 65
TAMSULOSIN HCL 58 51 48 26
SPIRIVA 57 33 52 59
BENICAR HCT 57 52 52 201
ALLOPURINOL 57 51 52 31
LEVETIRACETAM 54 12 55 89
CILOSTAZOL 54 29 55 232
HUMALOG MIX 75-25 51 37 57 296
RANITIDINE HCL 50 41 58 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.